SCHEMBL14667860

SCHEMBL14667860

CCCCCCOC(=O)c1ccccc1-c1c2ccc(=[N+](CC)CC)cc-2oc2cc(N(CC)CC)ccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ PPARG P37231 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.53
▸ NCOR2 Q9Y618 1/20 0.53
▸ TGM2 P21980 1/20 0.51
▸ FPR2 P25090 4/20 0.50
▸ CHRM1 P11229 2/20 0.45
▸ TLR7 Q9NYK1 1/20 0.45
▸ ABCB1 P08183 1/20 0.42
▸ CFTR P13569 1/20 0.41
▸ PAX8 Q06710 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ GOPC Q9HD26 1/20 0.41
▸ AVPR2 P30518 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18350813 1.00 USP2 (0.53) USP2MEN1POLBPPARGBLM
SCHEMBL13428258 1.00 USP2 (0.53) USP2MEN1POLBPPARGBLM
Hydrochloric Acid SCHEMBL29557664 0.99 USP2 (0.53) USP2MEN1POLBPPARGBLM
Perchlorate SCHEMBL29352706 0.97 USP2 (0.53) USP2MEN1POLBPPARGBLM
SCHEMBL22292200 0.97 USP2 (0.55) USP2MEN1POLBPPARGBLM
Hydrochloric Acid SCHEMBL29539118 0.96 USP2 (0.54) USP2MEN1POLBPPARGBLM
SCHEMBL17693120 0.94 USP2 (0.53) USP2MEN1POLBPPARGBLM
SCHEMBL17693127 0.94 USP2 (0.53) USP2MEN1POLBPPARGBLM
SCHEMBL10124264 0.94 USP2 (0.56) USP2MEN1POLBPPARGBLM
SCHEMBL18888026 0.92 USP2 (0.53) USP2MEN1POLBPPARGBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025841-A1 METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE BASF SE (DE) 2024-01-25 — — US disclosed
US-20240025841-A1 METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE BASF SE (DE) 2024-01-25 — — US disclosed
US-20230357129-A1 PROCESS FOR ISOLATING 2-(4'-DIETHYLAMINO-2'-HYDROXYBENZOYL)BENZOIC ACID HEXYL ESTER BASF SE (DE) 2023-11-09 — — US disclosed
US-20230357129-A1 PROCESS FOR ISOLATING 2-(4'-DIETHYLAMINO-2'-HYDROXYBENZOYL)BENZOIC ACID HEXYL ESTER BASF SE (DE) 2023-11-09 — — US disclosed
US-9625464-B2 Fluorescent probe for plasma cell identification and isolation, and plasma cell identification or isolation method using the probe NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA (JP) 2017-04-18 — — US disclosed
US-20130029325-A1 FLUORESCENT PROBE FOR PLASMA CELL IDENTIFICATION AND ISOLATION, AND PLASMA CELL IDENTIFICATION OR ISOLATION METHOD USING THE PROBE NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA (JP) 2013-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025841-A1 METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE HDHD5, APEH, ABHD6 USP2 376/4885MEN1 4641/4885POLB 541/4885
US-20130029325-A1 FLUORESCENT PROBE FOR PLASMA CELL IDENTIFICATION AND ISOLATION, AND PLASMA CELL IDENTIFICATION OR ISOLATION METHOD USING THE PROBE LNPK, CD79B, CHERP USP2 1877/4885MEN1 3398/4885POLB 4142/4885
US-20230357129-A1 PROCESS FOR ISOLATING 2-(4'-DIETHYLAMINO-2'-HYDROXYBENZOYL)BENZOIC ACID HEXYL ESTER HPD, HAAO, HACL2 USP2 90/4885MEN1 4283/4885POLB 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback